Ada Investment Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Ada Investment Management’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$113K	Buy	+12,316	New	+$103K	0.08%	360

Other funds holding SCLN

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sensato Investors San Francisco, California $122M AUM 5.69% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ada Investment Management's SCLN Position: Q4 2015 in Review

Ada Investment Management opened a new position in Sciclone Pharmaceuticals Inc (SCLN) in Q4 2015: 12,316 shares worth $113K. The stake represents 0.08% of the portfolio and ranks #360 among its holdings.

133 funds tracked by Wall St. Rank hold SCLN as of Q4 2015.

Ada Investment Management held 12,316 shares of Sciclone Pharmaceuticals Inc worth $113K as of Q4 2015.
Sciclone Pharmaceuticals Inc was a new Ada Investment Management position in Q4 2015.
Sciclone Pharmaceuticals Inc made up 0.08% of Ada Investment Management's portfolio in Q4 2015, its #360 holding.
133 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2015.

Based on Ada Investment Management's 13F filing for Q4 2015, filed 19 Feb 2016.